Characterization of HIV-1 entry inhibitors with broad activity against R5 and X4 viral strains

被引：0

作者：

Francesca Sironi

Mauro Malnati

Nicola Mongelli

Paolo Cozzi

Christina Guzzo

Silvia Ghezzi

Carles Martínez-Romero

Adolfo García-Sastre

Paolo Lusso

Daniela Jabes

Priscilla Biswas

机构：

[1] Unit of Human Virology,Department of Medicine

[2] Division of Immunology,Unit of Molecular Immunology, Division of Genetics and Cell Biology

[3] Transplantation and Infectious Diseases,undefined

[4] San Raffaele Hospital,undefined

[5] Unit of Viral Pathogens and Biosafety,undefined

[6] Division of Immunology,undefined

[7] Transplantation and Infectious Diseases,undefined

[8] San Raffaele Hospital,undefined

[9] Laboratory of Immunoregulation,undefined

[10] National Institute of Allergy and Infectious Diseases (NIAID),undefined

[11] National Institutes of Health (NIH),undefined

[12] Department of Microbiology,undefined

[13] Global Health and Emerging Pathogens Institute,undefined

[14] Division of Infectious Diseases,undefined

[15] Icahn School of Medicine at Mount Sinai,undefined

[16] NeED Pharmaceuticals srl,undefined

[17] San Raffaele Hospital,undefined

来源：

Journal of Translational Medicine | / 13卷

关键词：

Suramin; Maraviroc; Enfuvirtide; Plerixafor; Distamycin;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

共 50 条

[31] Peptide-Derivatized SB105-A10 Dendrimer Inhibits the Infectivity of R5 and X4 HIV-1 Strains in Primary PBMCs and Cervicovaginal Histocultures
Bon, Isabella
Lembo, David
Rusnati, Marco
Clo, Alberto
Morini, Silvia
Miserocchi, Anna
Bugatti, Antonella
Grigolon, Sonia
Musumeci, Giuseppina
Landolfo, Santo
Re, Maria Carla
Gibellini, Davide
PLOS ONE, 2013, 8 (10):
[32] Post-entry events of efficient R5 vs. inefficient X4 HIV-1 replication in primary CD4+ T lymphocytes, a transcriptome analysis
Mariani, Samanta A.
Crotti, Andrea
Vicenzi, Elisa
Huang Dawei
Lempicky, Richard
Cicala, Claudia
Arthos, James
Poli, Guido
RETROVIROLOGY, 2009, 6
[33] Post-entry events of efficient R5 vs. inefficient X4 HIV-1 replication in primary CD4+T lymphocytes, a transcriptome analysis
Samanta A Mariani
Andrea Crotti
Elisa Vicenzi
Huang Dawei
Richard Lempicky
Claudia Cicala
James Arthos
Guido Poli
Retrovirology, 6
[34] R5 human immunodeficiency virus type 1 (HIV-1) replicates more efficiently in primary CD4+ T-cell cultures than X4 HIV-1
Schweighardt, B
Roy, AM
Meiklejohn, DA
Grace, EJ
Moretto, WJ
Heymann, JJ
Nixon, DF
JOURNAL OF VIROLOGY, 2004, 78 (17) : 9164 - 9173
[35] Selective Transmission of R5 HIV-1 over X4 HIV-1 at the Dendritic Cell-T Cell Infectious Synapse Is Determined by the T Cell Activation State
Yamamoto, Takuya
Tsunetsugu-Yokota, Yasuko
Mitsuki, Yu-ya
Mizukoshi, Fuminori
Tsuchiya, Takatsugu
Terahara, Kazutaka
Inagaki, Yoshio
Yamamoto, Naoki
Kobayashi, Kazuo
Inoue, Jun-ichiro
PLOS PATHOGENS, 2009, 5 (01)
[36] Enhanced infectivity of HIV-1 by X4 HIV-1 coinfection
Maeda, Y
Yusa, K
Harada, S
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2003, 308 (04) : 906 - 913
[37] The Immunomodulatory Agent Rapamycin Potentiates the Antiviral Activity of the Fusion Inhibitor T20 Against R5 Strains of HIV-1
Alonso Heredia
Anthony Amoroso
Charles Davis
Nhut Le
Douty Bamba
Robert Gallo
Robert Redfield
Retrovirology, 2
[38] The immunomodulatory agent rapamycin potentiates the antiviral activity of the fusion inhibitor T20 against R5 strains of HIV-1
Heredia, Alonso
Amoroso, Anthony
Davis, Charles
Le, Nhut
Bamba, Douty
Gallo, Robert
Redfield, Robert
RETROVIROLOGY, 2005, 2 (Suppl 1)
[39] The immunomodulatory agent rapamycin potentiates the antiviral activity of the fusion inhibitor T20 against R5 strains of HIV-1
Heredia, Alonso
Amoroso, Anthony
Davis, Charles
Le, Nhut
Bamba, Douty
Gallo, Robert
Redfield, Robert
RETROVIROLOGY, 2005, 2 (Suppl 1)
[40] The Immunomodulatory Agent Rapamycin Potentiates the Antiviral Activity of the Fusion Inhibitor T20 Against R5 Strains of HIV-1
Alonso Heredia
Anthony Amoroso
Charles Davis
Nhut Le
Douty Bamba
Robert Gallo
Robert Redfield
Retrovirology, 2

← 1 2 3 4 5 →